Thu, May 10, 2018
Wed, May 9, 2018
Tue, May 8, 2018
Mon, May 7, 2018
Fri, May 4, 2018
Thu, May 3, 2018
Wed, May 2, 2018
Tue, May 1, 2018
Mon, April 30, 2018
Fri, April 27, 2018

Raghuram Selvaraju Initiated (BTAI) at Strong Buy and Held Target at $25 on, May 3rd, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. g-buy-and-held-target-at-25-on-may-3rd-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $25 on, May 3rd, 2018.

Raghuram has made no other calls on BTAI in the last 4 months.



There are 2 other peers that have a rating on BTAI. Out of the 2 peers that are also analyzing BTAI, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $18 on, Monday, April 2nd, 2018
  • Geoff Meacham of "Barclays" Initiated at Buy and Held Target at $15 on, Monday, April 2nd, 2018

Publication Contributing Sources